🇰🇷 South Korea Country × Condition
cardiovascular diseases Clinical Trials in South Korea
Active clinical trials for cardiovascular diseases with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 4, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇰🇷 South Korea
Active Trials in South Korea (3)
NCT06642623 Phase 4
Recruiting
A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients
Enrollment
2,862 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial → NCT07595718
Recruiting
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
Enrollment
1,000 pts
Country
🇰🇷 South Korea
Jae Yong Jeon, MD
View Trial → NCT06826872 Phase 2
Recruiting
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
Enrollment
252 pts
Country
🇰🇷 South Korea
Shin Poong Pharmaceutical Co. Ltd.
View Trial → Frequently Asked Questions
How many cardiovascular diseases clinical trials are active in South Korea?
There are currently 3 active clinical trials for cardiovascular diseases with sites in South Korea, of which 3 are actively recruiting patients.
How can I join a cardiovascular diseases clinical trial in South Korea?
To join a cardiovascular diseases clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are cardiovascular diseases trials in South Korea?
Active cardiovascular diseases trials in South Korea span Phase 4, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology